SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-037161
Filing Date
2024-03-27
Accepted
2024-03-27 16:05:17
Documents
12
Period of Report
2024-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eras-20240327.htm   iXBRL 8-K 37621
2 EX-99.1 eras-ex99_1.htm EX-99.1 143867
  Complete submission text file 0000950170-24-037161.txt   310088

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eras-20240327.xsd EX-101.SCH 25792
15 EXTRACTED XBRL INSTANCE DOCUMENT eras-20240327_htm.xml XML 4879
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 24790571
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)